Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Jun 16;23(9):1863–1872. doi: 10.1158/1055-9965.EPI-14-0102

Figure 1.

Figure 1

Figure 1a. Adjusted ORs (95% CIs) for glioma in relation to categories of cumulative occupational ELF-MF exposure in the 1–4, 5–9, and 10+ year time windows prior to the date of diagnosis/reference date from a simultaneous exposure time windows model with cutpoints based on the 25th, 50th, 75th, and 90th percentile, INTEROCC study, 2000–2004, Australia, Canada, France, Germany, Israel, New Zealand, and United Kingdom

Figure 1b. Adjusted ORs (95% CIs) for meningioma in relation to categories of cumulative occupational ELF-MF exposure in the 1–4, 5–9, and 10+ year time windows prior to the date of diagnosis/reference date from a simultaneous exposure time windows model with cutpoints based on the 25th, 50th, 75th, and 90th percentile, INTEROCC study, 2000–2004, Australia, Canada, France, Germany, Israel, New Zealand, and United Kingdom